Severe or lethal toxicities upon capecitabine intake: is DPYD genetic polymorphism the ideal culprit?
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference10 articles.
1. Moving forward with capecitabine: a glimpse of the future;Biganzoli;Oncologist,2002
2. Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil;van Kuilenburg;Eur. J. Cancer,2004
3. TPMT, UGT1A1 and DPYD: genotyping to ensure safer cancer therapy?;Maitland;Trends Pharmacol. Sci.,2006
4. Profiling dihydropyrimidine dehydrogenase deficiency in patients with cancer undergoing 5-fluorouracil/capecitabine therapy;Mercier;Clin. Colorectal Cancer,2006
5. Toxic death-case after capecitabine+oxaliplatin (XELOX) administration: probable implication of dihydropyrimidine deshydrogenase deficiency;Ciccolini;Cancer Chemother. Pharmacol.,2006
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency;European Journal of Cancer;2023-03
2. Impact of Guidelines Regarding Dihydropyrimidine Dehydrogenase (DPD) Deficiency Screening Using Uracil-Based Phenotyping on the Reduction of Severe Side Effect of 5-Fluorouracil-Based Chemotherapy: A Propension Score Analysis;Pharmaceutics;2022-10-06
3. Synthesis of Purines and Related Molecules by Cyclization Reactions of Heterocyclic Enamines;Synlett;2021-10-22
4. Leukoencephalopathy with transient splenial lesions related to 5‐fluorouracil or capecitabine;European Journal of Neurology;2021-04-19
5. Fluorouracil or Capecitabine Overdose;Oncologic Emergency Medicine;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3